PETER G TRABER
CIK 1284500 · Chief Medical Officer · last filed 2023-09-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$702.9K
Companies
5
Total Filings
53
Lifetime Open-Market Net
-$777.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. (SELB) Delisted | Chief Medical Officer | 451,826 | $0.88 | $398.1K | $306.4K | 16 | 2023-09-26 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Director | 9,946 | $6.40 | $63.6K | $0 | 10 | 2022-01-12 |
| GALT | President & CEO | 207,333 | $3.39 | $702.9K | -$1.16M | 4 | 2018-06-15 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | President & CEO | 107,333 | — | — | $77.3K | 16 | 2016-12-06 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Director | 10,000 | — | — | $0 | 2 | 2015-06-04 |
Recent Filings · Page 3 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-10 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +8,747 | $0 | EDGAR |
| 2018-06-15 | GALT | Mixed | — | -$664.0K | EDGAR |
| 2018-06-12 | GALT | Mixed | — | -$349.1K | EDGAR |
| 2018-05-24 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-01-17 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-01-10 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-18 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +2,565 | $0 | EDGAR |
| 2017-01-31 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +1,650 | $0 | EDGAR |
| 2016-12-06 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-23 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.